(Q33371271)

26 July 2017

High-dose intravenous IgG treatment and renal function (English)

1 reference

26 July 2017

J. Schifferli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

M. Leski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

H. Favre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

P. Imbach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

U. Nydegger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

K. Davies

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671473

25 October 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

26 July 2017

23 February 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1671473

full work available at URL

25 October 2022

https://api.elsevier.com/content/article/PII:014067369193395P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

https://api.elsevier.com/content/article/PII:014067369193395P?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

25 October 2022

1 reference

26 July 2017

337

1 reference

26 July 2017

457-458

1 reference

26 July 2017

8739

1 reference

Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

26 July 2017

1

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

Intravenous immunoglobulins as therapeutic agents

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

Limitations of creatinine as a filtration marker in glomerulopathic patients

25 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

Serial assessment of glomerular filtration rate in lupus nephropathy

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93395-P

25 October 2022

Identifiers

1 reference

26 July 2017

1 reference